Literature DB >> 24934464

Glycemic management in patients with coronary artery disease and prediabetes or type 2 diabetes mellitus.

Allison B Goldfine1, Eng-Joo Phua2, Martin J Abrahamson2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24934464      PMCID： PMC4401832          DOI： 10.1161/CIRCULATIONAHA.113.006634

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  19 in total

1.  Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.

Authors:  Benjamin M Scirica; Deepak L Bhatt; Eugene Braunwald; P Gabriel Steg; Jaime Davidson; Boaz Hirshberg; Peter Ohman; Robert Frederich; Stephen D Wiviott; Elaine B Hoffman; Matthew A Cavender; Jacob A Udell; Nihar R Desai; Ofri Mosenzon; Darren K McGuire; Kausik K Ray; Lawrence A Leiter; Itamar Raz
Journal:  N Engl J Med       Date:  2013-09-02       Impact factor: 91.245

2.  Alogliptin after acute coronary syndrome in patients with type 2 diabetes.

Authors:  William B White; Christopher P Cannon; Simon R Heller; Steven E Nissen; Richard M Bergenstal; George L Bakris; Alfonso T Perez; Penny R Fleck; Cyrus R Mehta; Stuart Kupfer; Craig Wilson; William C Cushman; Faiez Zannad
Journal:  N Engl J Med       Date:  2013-09-02       Impact factor: 91.245

3.  Pioglitazone for diabetes prevention in impaired glucose tolerance.

Authors:  Ralph A DeFronzo; Devjit Tripathy; Dawn C Schwenke; MaryAnn Banerji; George A Bray; Thomas A Buchanan; Stephen C Clement; Robert R Henry; Howard N Hodis; Abbas E Kitabchi; Wendy J Mack; Sunder Mudaliar; Robert E Ratner; Ken Williams; Frankie B Stentz; Nicolas Musi; Peter D Reaven
Journal:  N Engl J Med       Date:  2011-03-24       Impact factor: 91.245

4.  Cardiovascular consequences of drugs used for the treatment of diabetes: potential promise of incretin-based therapies.

Authors:  Kiwon Ban; Sonya Hui; Daniel J Drucker; Mansoor Husain
Journal:  J Am Soc Hypertens       Date:  2009-06-03

5.  Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials.

Authors:  Naveed Sattar; David Preiss; Heather M Murray; Paul Welsh; Brendan M Buckley; Anton J M de Craen; Sreenivasa Rao Kondapally Seshasai; John J McMurray; Dilys J Freeman; J Wouter Jukema; Peter W Macfarlane; Chris J Packard; David J Stott; Rudi G Westendorp; James Shepherd; Barry R Davis; Sara L Pressel; Roberto Marchioli; Rosa Maria Marfisi; Aldo P Maggioni; Luigi Tavazzi; Gianni Tognoni; John Kjekshus; Terje R Pedersen; Thomas J Cook; Antonio M Gotto; Michael B Clearfield; John R Downs; Haruo Nakamura; Yasuo Ohashi; Kyoichi Mizuno; Kausik K Ray; Ian Ford
Journal:  Lancet       Date:  2010-02-16       Impact factor: 79.321

6.  Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial.

Authors:  Matthew C Riddle; Walter T Ambrosius; David J Brillon; John B Buse; Robert P Byington; Robert M Cohen; David C Goff; Saul Malozowski; Karen L Margolis; Jeffrey L Probstfield; Adrian Schnall; Elizabeth R Seaquist
Journal:  Diabetes Care       Date:  2010-05       Impact factor: 19.112

7.  Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial.

Authors:  Jean-Louis Chiasson; Robert G Josse; Ramon Gomis; Markolf Hanefeld; Avraham Karasik; Markku Laakso
Journal:  JAMA       Date:  2003-07-23       Impact factor: 56.272

Review 8.  Cardiac ATP-sensitive K+ channels: regulation by intracellular nucleotides and K+ channel-opening drugs.

Authors:  A Terzic; A Jahangir; Y Kurachi
Journal:  Am J Physiol       Date:  1995-09

9.  Dipeptidyl peptidase-4 inhibitors and cardiovascular risk: a meta-analysis of randomized clinical trials.

Authors:  M Monami; B Ahrén; I Dicembrini; E Mannucci
Journal:  Diabetes Obes Metab       Date:  2012-09-20       Impact factor: 6.577

10.  The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: an intent-to-treat analysis of the DPP/DPPOS.

Authors: 
Journal:  Diabetes Care       Date:  2012-04       Impact factor: 19.112
View more
  4 in total

1.  Coronary artery disease in type 2 diabetes mellitus: Recent treatment strategies and future perspectives.

Authors:  Ryo Naito; Takatoshi Kasai
Journal:  World J Cardiol       Date:  2015-03-26

2.  Single Nucleotide Polymorphism rs17173608 in the Chemerin Encoding Gene: Is It a Predictor of Insulin Resistance and Severity of Coronary Artery Disease in Non-Obese Type 2 Diabetes?

Authors:  Sangeetha Perumalsamy; Wan Azman Wan Ahmad; Hasniza Zaman Huri
Journal:  Healthcare (Basel)       Date:  2021-05-23

3.  Beyond type 2 diabetes, obesity and hypertension: an axis including sleep apnea, left ventricular hypertrophy, endothelial dysfunction, and aortic stiffness among Mexican Americans in Starr County, Texas.

Authors:  Craig L Hanis; Susan Redline; Brian E Cade; Graeme I Bell; Nancy J Cox; Jennifer E Below; Eric L Brown; David Aguilar
Journal:  Cardiovasc Diabetol       Date:  2016-06-08       Impact factor: 9.951

4.  Non-culprit plaque characteristics in acute coronary syndrome patients with raised hemoglobinA1c: an intravascular optical coherence tomography study.

Authors:  Shaotao Zhang; Jiannan Dai; Haibo Jia; Sining Hu; Hongwei Du; Ning Li; Yongpeng Zou; Yanan Zou; Shenhong Jing; Yan Wang; Rong Sun; Bo Yu
Journal:  Cardiovasc Diabetol       Date:  2018-06-15       Impact factor: 9.951
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.